Healthcare -
Biotechnology - NASDAQ - US
$ 61.53
0.457 %
$ 11.7 B
Market Cap
37.07
P/E
BMRN - REVENUE
Revenue BMRN - BioMarin Pharmaceutical Inc.
2.42 B
LAST VALUE
14.47%
2 YEAR CAGR
10.16%
5 YEAR CAGR
16.00%
10 YEAR CAGR